Welcome to LookChem.com Sign In|Join Free

CAS

  • or

105336-07-0

Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

105336-07-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]-

    Cas No: 105336-07-0

  • Need to discuss

  • No requirement

  • Adequate

  • LEAP CHEM Co., Ltd.
  • Contact Supplier
  • 105336-07-0 Structure

  • Basic information

    1. Product Name: Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]-
    2. Synonyms:
    3. CAS NO:105336-07-0
    4. Molecular Formula: C13H11N5O6
    5. Molecular Weight: 333.26
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 105336-07-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]-(105336-07-0)
    11. EPA Substance Registry System: Acetamide, 2-[(2,4-dioxo-1-imidazolidinyl)imino]-N-[2-(2-nitrophenyl)-2-oxoethyl]-(105336-07-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 105336-07-0(Hazardous Substances Data)

105336-07-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 105336-07-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,3,3 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 105336-07:
(8*1)+(7*0)+(6*5)+(5*3)+(4*3)+(3*6)+(2*0)+(1*7)=90
90 % 10 = 0
So 105336-07-0 is a valid CAS Registry Number.

105336-07-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(Z)-2,4-Dioxo-imidazolidin-1-ylimino]-N-[2-(2-nitro-phenyl)-2-oxo-ethyl]-acetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105336-07-0 SDS

105336-07-0Relevant articles and documents

1-methylene>amino>-2,4-imidazolidinediones, a New Class of Skeletal Muscle Relaxants

White, R.L.,Wessels, F.L.,Schwan, T.J.,Ellis, K.O.

, p. 263 - 266 (2007/10/02)

A series of 1-methylene>amino>-2,4-imidazolidinediones (6a-t) was synthesized, and the compounds were evaluated for direct skeletal muscle inhibition in the pithed rat gastrocnemius muscle preparation.The correctness of structural assignment of the new series was verified by alternate, unequivocal synthesis of one representative structure (6f).The phenyloxazoles 6d, 6g, 6j, 6k,and 6l exhibited significant skeletal muscle relaxant activity when administered intravenously and orally.The skeletal muscle relaxant effect of these five compounds is similar to that of other direct-acting skeletal muscle relaxants.The oxazole moiety proved to be an acceptable isosteric replacement for furan, as the biological activity in the oxazole series was retained.The synthesis of this new class of compounds is described, and pharmacologic evaluation data are presented.A discussion of structure-activity relationships is also presented.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105336-07-0